Axiscades Technologies Ltd Q1 FY27 Results

Axiscades reported a consolidated net loss of ₹14.76 Cr for the quarter ended June 30, 2026 (Q1 FY27) — a sharp reversal from the ₹20.86 Cr profit a year ago and the marginal ₹0.41 Cr profit in Q4 FY26 — even as total revenue (continuing + discontinued operations) grew 42.2% YoY to ₹346.60 Cr (+27.0% QoQ from ₹273.01 Cr). The swing was driven almost entirely by a ₹21.81 Cr one-off advisory/professional-fee charge tied to the ongoing divestment of two legacy service lines to Akkodis, booked within discontinued operations; adjusted for this item, PAT would have been a positive ~₹7.05 Cr, still down ~66.2% YoY on an adjusted basis. Consolidated basic EPS was -₹3.49 versus +₹4.88 a year ago. Standalone results mirrored the pattern — a ₹13.87 Cr net loss (EPS -₹3.26) against a ₹6.56 Cr profit a year ago.

Consolidated NPM swung to roughly -4.3% from +8.2% a year ago. The pressure sits mainly in continuing operations (the post-carve-out core of Defence plus retained Technology Services), where revenue nearly doubled YoY to ₹183.35 Cr (+94.2%) — Defence alone grew 111.5% to ₹124.99 Cr, comfortably ahead of management's guided >40% core-domain growth — but costs grew faster: employee expense +30.2% to ₹48.30 Cr, finance costs +36.8% to ₹8.87 Cr, and depreciation +82.9% to ₹8.75 Cr, as the company ramps capacity for the new large-scale Defence facilities (radars, missiles) flagged in its guidance. That capex shows up directly in the quarter's corporate actions: a ₹39.4 Cr land acquisition completed July 24, 2026. Discontinued operations (the businesses being sold) also cooled — pre-exceptional profit fell 34.1% YoY to ₹16.39 Cr even as their revenue rose 9.4% to ₹163.25 Cr — margin compression that, combined with the Akkodis deal costs, did most of the damage to the bottom line.

The stock went into the print at ₹1,535, down 4.7% over the past month of trading.

For context: PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.

We have no management press release for this specific result on file, so this read is based on the filing alone. Management's prior guidance (Q3 FY26 concall) called for 40-50% annual EPS growth in both FY26 and FY27 and EBITDA margin expansion from ~17% (FY26) to 20% (FY27), underpinned by a shift toward higher-margin defence products. Q1's swing to a loss — or even the adjusted ~66% YoY PAT decline — is a weak opening quarter against that bar, though it is one of four and dominated by a one-off deal cost; the revenue-mix and core-growth legs of the guidance, by contrast, are tracking well. No specific street/consensus estimate for this quarter turned up in a web search; the only external figure on record is management's own FY27 consolidated revenue trajectory of ~₹1,377 Cr (reiterated after FY26 results), against which this quarter's ₹346.60 Cr run-rate is broadly on pace. The quarter's governance actions — Ashmita Sethi's appointment as independent director (Aug 11) and the board/committee reconstitution — are housekeeping tied to the upcoming Akkodis transaction rather than operational drivers.